Published in Immunol Commun on January 01, 1973
B-1 lymphocytes in mice and nonhuman primates. Ann N Y Acad Sci (2015) 0.78
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Evaluation of a dispensing instrument (Dynatech MIC-2000) for preparing microtiter antibiotic plates and testing their potency during storage. Antimicrob Agents Chemother (1978) 4.37
Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med (1980) 3.95
Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians (1976) 3.49
A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. J Immunol Methods (1980) 2.65
B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA (1984) 2.63
DNP-Lys-ficoll: a T-independent antigen which elicits both IgM and IgG anti-DNP antibody-secreting cells. J Immunol (1975) 2.40
Immune response after splenectomy. Lancet (1978) 2.31
Cellular requirements for the primary in vitro antibody response to DNP-ficoll. J Exp Med (1974) 2.10
Immunodeterminant specificity of human immunity to type III group B streptococcus. J Exp Med (1979) 2.06
Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1986) 1.99
Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N Engl J Med (1978) 1.86
The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus. J Immunol (1976) 1.80
Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect Immun (1986) 1.79
Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med (1986) 1.76
Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis (1981) 1.71
The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice. Am J Trop Med Hyg (1973) 1.66
Capsulation of pneumococcus with soluble C-like (Cs) polysaccharide. I. Biological and genetic properties of Cs pneumococcal strains. J Exp Med (1968) 1.65
Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis (1984) 1.62
Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides. Infect Immun (1979) 1.61
Impaired antibody responses to pneumococcal polysaccharide in elderly patients with low serum vitamin B12 levels. Ann Intern Med (1996) 1.52
The transfer of allergic thyroiditis in histocompatible guinea pigs by lymph node cells. J Immunol (1967) 1.48
Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect Immun (1980) 1.43
Failure of pneumococcal vaccine in children with sickle-cell disease. N Engl J Med (1979) 1.43
Plasmodium knowlesi: functional immunity and antimerozoite antibodies in rhesus monkeys after repeated infection. Exp Parasitol (1977) 1.38
Counting of Schistosoma mansoni eggs in feces. Comparison of a filtration technique and a dilution technique. J Parasitol (1968) 1.36
Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report. Lancet (1980) 1.35
Some biological properties of Pneumococcus type 37 and the chemistry of its capsular polysaccharide. J Exp Med (1970) 1.34
Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J Infect Dis (1980) 1.32
Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest (1985) 1.32
Cyclophosphamide pretreatment and protection against malaria. Infect Immun (1976) 1.25
Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine. Infect Immun (1998) 1.24
Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med (1979) 1.23
Need for agreement on a single pneumococcal vaccine formulation. Lancet (1980) 1.21
Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas. J Infect Dis (1978) 1.21
Epidemiologic studies of Streptococcus pneumoniae in infants: antibody response to nasopharyngeal carriage of types 3, 19, and 23. J Infect Dis (1981) 1.21
Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid. Infect Immun (1990) 1.20
Endogenous immune uveitis. The role of serum sickness. Arch Ophthalmol (1971) 1.19
Prevention of recrudescent malaria in nude mice by thymic grafting or by treatment with hyperimmune serum. Infect Immun (1977) 1.15
Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Rev Infect Dis (1981) 1.15
Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome. Pediatrics (1982) 1.13
Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study. Chest (1987) 1.13
Monoclonal antibodies to parasite antigens found in the serum of Dirofilaria immitis-infected dogs. J Immunol (1985) 1.12
Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates. Infect Immun (1988) 1.12
Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun (1984) 1.12
Immunologic studies in pneumococcal disease. J Lab Clin Med (1977) 1.12
The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice. J Immunol (1982) 1.12
Plasmodium vinckei: production of chloroquine-resistant strain. Exp Parasitol (1969) 1.11
Activity of chlorinated lincomycin analogues against Plasmodium cynomolgi in rhesus monkeys. Am J Trop Med Hyg (1969) 1.09
Effect of chronic exposure of PCB (Aroclor 1254) on specific and nonspecific immune parameters in the rhesus (Macaca mulatta) monkey. Fundam Appl Toxicol (1991) 1.08
Antibody response to vaccination with pneumococcal capsular polysaccharides in splenectomized children. Acta Paediatr Scand (1982) 1.08
Maternal-fetal transfer of pneumococcal capsular polysaccharide antibodies. Am J Dis Child (1985) 1.08
Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae. Infect Immun (1985) 1.08
Activity of two chlorinated lincomycin analogues against chloroquine-resistant falciparum malaria in owl monkeys. Antimicrob Agents Chemother (1972) 1.08
Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens. N Engl J Med (1980) 1.07
Treatment of a presumed case of sympathetic ophthalmia with methotrexate. Arch Ophthalmol (1966) 1.07
Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine. Rev Infect Dis (1981) 1.06
Schistosoma mansoni infection in rhesus monkeys: changes in egg production and egg distribution in prolonged infections in intact and splenectomized monkeys. Ann Trop Med Parasitol (1969) 1.05
Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med (1986) 1.04
Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus. J Infect Dis (1989) 1.04
Antibody and immunoglobulin synthesis in germfree and conventional mice infected with Eperythrozoon coccoides. Am J Trop Med Hyg (1972) 1.04
Subpopulations of antibodies to phosphocholine in human serum. J Immunol (1984) 1.04
Immune response to acute otitis media: association between middle ear fluid antibody and the clearing of clinical infection. J Clin Microbiol (1976) 1.04
Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia. Pediatr Infect Dis J (1990) 1.03
The antibody responses to pneumococcal capsular polysaccharides in aged individuals. Proc Soc Exp Biol Med (1980) 1.02
Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage. Rev Infect Dis (1981) 1.00
Difference in surface charge between host cells and malarial parasites. J Parasitol (1973) 1.00
Experimental otitis media in chinchillas following nasal colonization with type 7F Streptococcus pneumoniae: prevention after vaccination with pneumococcal capsular polysaccharide. J Infect Dis (1979) 0.99
Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens. Infect Immun (1987) 0.99
Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels. J Allergy Clin Immunol (1988) 0.98
Immunosuppression in rodent malaria. Effect upon recovery and antibody response. Am J Trop Med Hyg (1971) 0.98
Comparative adjuvant activities of Legionella pneumophila and Mycobacterium tuberculosis. Int Arch Allergy Appl Immunol (1984) 0.98
Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid. Pediatr Infect Dis J (1997) 0.97
Long-term persistence of antibody following immunization with pneumococcal polysaccharide vaccine. Proc Soc Exp Biol Med (1983) 0.97
Pneumococcal vaccine: a tool for the evaluation of the B-cell function of the immune system. Proc Soc Exp Biol Med (1983) 0.97
Immunological function in post-traumatic splenosis. Clin Immunol Immunopathol (1995) 0.96
Detection of circulating parasite antigens in canine dirofilariasis by counterimmunoelectrophoresis. Am J Trop Med Hyg (1984) 0.95
Pneumococcal vaccine in normal children. Primary and secondary vaccination. Am J Dis Child (1983) 0.95
Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin. Infect Immun (1992) 0.95
Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease. Ann Intern Med (1986) 0.95
Vaccine-type pneumococcal pneumonia. Occurrence after vaccination in an asplenic patient. JAMA (1979) 0.95
Response of patients with Hodgkin's disease to pneumococcal vaccine. Ann Intern Med (1979) 0.95
Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides. J Pediatr (1984) 0.95
Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination. Vaccine (1991) 0.95
Antibody response to capsular polysaccharide vaccine of Streptococcus pneumoniae in patients with nephrotic syndrome. J Infect Dis (1978) 0.93
Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med (1983) 0.93
Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers. Infect Immun (1982) 0.93
Antibody responses to polyvalent pneumococcal vaccine in infants with sickle cell anemia. J Pediatr (1980) 0.93
Pneumococcal antibody levels one decade after immunization of healthy adults. Am J Med Sci (1987) 0.93
Function of the replanted spleen in dogs. J Trauma (1982) 0.92
Graphical method for evaluating antibody response to vaccines. Infect Immun (1980) 0.92
Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia. J Pediatr (1984) 0.92
Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides. Clin Immunol Immunopathol (1987) 0.91
Experimental autoimmune renal cortical tubulointerstitial disease in guinea pigs lacking the fourth component of complement (C4). J Immunol (1974) 0.91
Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL. J Immunol (1991) 0.91
Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3. J Lab Clin Med (1988) 0.91
A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum (1979) 0.90